21.1% Below Target

The consensus Wall Street price target for CRH is $134.75, representing 21.1% upside from the current price of $111.24. With 20 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.

CRH has a consensus rating of "Buy" based on 20 Wall Street analysts. The rating breakdown is predominantly bullish, with 14 Buy/Strong Buy ratings. The consensus 12-month price target of $134.75 implies 21.1% upside from current levels.

With a forward P/E of 18.7197x, CRH trades at a relatively low valuation. The consensus target of $134.75 implies 21.1% appreciation, suggesting meaningful undervaluation.

The most bullish Wall Street analyst has a price target of $147 for CRH, while the most conservative target is $120. The consensus of $134.75 represents the median expectation. Our quantitative valuation model projects a bull case target of $164 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

CRH is well covered by analysts, with 20 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 14 have Buy ratings, 6 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

The 12-month CRH stock forecast based on 20 Wall Street analysts shows a consensus price target of $134.75, with estimates ranging from $120 (bear case) to $147 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $124, with bear/bull scenarios of $78/$164.

Our quantitative valuation model calculates CRH's fair value at $124 (base case), with a bear case of $78 and bull case of $164. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 47/100.

CRH trades at a forward P/E ratio of 18.7x based on next-twelve-months earnings estimates compared to a trailing P/E of 20.2x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Wall Street analysts are very optimistic on CRH, with a "Buy" consensus rating and $134.75 price target (21.1% upside). 14 of 20 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

CRH analyst price targets range from $120 to $147, a 20% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $134.75 consensus represents the middle ground. Our model's $78-$164 range provides an independent fundamental perspective.